1ykr

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1ykr" size="450" color="white" frame="true" align="right" spinBox="true" caption="1ykr, resolution 1.8&Aring;" /> '''Crystal structure of...)
Line 1: Line 1:
-
[[Image:1ykr.gif|left|200px]]<br />
+
[[Image:1ykr.gif|left|200px]]<br /><applet load="1ykr" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1ykr" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1ykr, resolution 1.8&Aring;" />
caption="1ykr, resolution 1.8&Aring;" />
'''Crystal structure of cdk2 with an aminoimidazo pyridine inhibitor'''<br />
'''Crystal structure of cdk2 with an aminoimidazo pyridine inhibitor'''<br />
==Overview==
==Overview==
-
Structure-based design approach was successfully used to guide the, evolution of imidazopyridine scaffold yielding new structural class of, highly selective inhibitors of cyclin dependent kinases that were able to, form a new interaction with an identified residue of the protein, Lys89., Compounds from this series have shown no detectable effect when tested, against a representative set of other serine/threonine kinases such as, GSK3beta, CAMKII, PKA, PKC-alpha,beta,epsilon,gamma. Compound 2i inhibits, proliferation in HCT 116 cells in tissue culture. Synthesis, co-crystal, structure of CDK2 in complex with compound 2i, and preliminary SAR study, are disclosed.
+
Structure-based design approach was successfully used to guide the evolution of imidazopyridine scaffold yielding new structural class of highly selective inhibitors of cyclin dependent kinases that were able to form a new interaction with an identified residue of the protein, Lys89. Compounds from this series have shown no detectable effect when tested against a representative set of other serine/threonine kinases such as GSK3beta, CAMKII, PKA, PKC-alpha,beta,epsilon,gamma. Compound 2i inhibits proliferation in HCT 116 cells in tissue culture. Synthesis, co-crystal structure of CDK2 in complex with compound 2i, and preliminary SAR study are disclosed.
==About this Structure==
==About this Structure==
-
1YKR is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with 628 as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1YKR OCA].
+
1YKR is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=628:'>628</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1YKR OCA].
==Reference==
==Reference==
Line 15: Line 14:
[[Category: Non-specific serine/threonine protein kinase]]
[[Category: Non-specific serine/threonine protein kinase]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Brooks, H.B.]]
+
[[Category: Brooks, H B.]]
[[Category: Hamdouchi, C.]]
[[Category: Hamdouchi, C.]]
[[Category: Jaramillo, C.]]
[[Category: Jaramillo, C.]]
Line 25: Line 24:
[[Category: cell cycle division protein kinase 2]]
[[Category: cell cycle division protein kinase 2]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:21:26 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:06:19 2008''

Revision as of 14:06, 21 February 2008


1ykr, resolution 1.8Å

Drag the structure with the mouse to rotate

Crystal structure of cdk2 with an aminoimidazo pyridine inhibitor

Overview

Structure-based design approach was successfully used to guide the evolution of imidazopyridine scaffold yielding new structural class of highly selective inhibitors of cyclin dependent kinases that were able to form a new interaction with an identified residue of the protein, Lys89. Compounds from this series have shown no detectable effect when tested against a representative set of other serine/threonine kinases such as GSK3beta, CAMKII, PKA, PKC-alpha,beta,epsilon,gamma. Compound 2i inhibits proliferation in HCT 116 cells in tissue culture. Synthesis, co-crystal structure of CDK2 in complex with compound 2i, and preliminary SAR study are disclosed.

About this Structure

1YKR is a Single protein structure of sequence from Homo sapiens with as ligand. Active as Non-specific serine/threonine protein kinase, with EC number 2.7.11.1 Full crystallographic information is available from OCA.

Reference

Structure-based design of a new class of highly selective aminoimidazo[1,2-a]pyridine-based inhibitors of cyclin dependent kinases., Hamdouchi C, Zhong B, Mendoza J, Collins E, Jaramillo C, De Diego JE, Robertson D, Spencer CD, Anderson BD, Watkins SA, Zhang F, Brooks HB, Bioorg Med Chem Lett. 2005 Apr 1;15(7):1943-7. PMID:15780638

Page seeded by OCA on Thu Feb 21 16:06:19 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools